phenylalanine has been researched along with phenylmercuric acetate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benbow, U; Butticè, G; Kurkinen, M; Nagase, H | 1 |
Albanell, J; Arribas, J; Baselga, J; Codony-Servat, J; Molina, MA; Rojo, F | 1 |
2 other study(ies) available for phenylalanine and phenylmercuric acetate
Article | Year |
---|---|
Characterization of the 46-kDa intermediates of matrix metalloproteinase 3 (stromelysin 1) obtained by site-directed mutation of phenylalanine 83.
Topics: alpha-Macroglobulins; Amino Acid Sequence; Animals; Base Sequence; CHO Cells; Chymotrypsin; Cloning, Molecular; Cricetinae; Enzyme Activation; Enzyme Precursors; Glycoproteins; Hydrolysis; Kinetics; Leukocyte Elastase; Matrix Metalloproteinase 3; Metalloendopeptidases; Molecular Sequence Data; Mutagenesis, Site-Directed; Pancreatic Elastase; Phenylalanine; Phenylmercuric Acetate; Recombinant Proteins; Substrate Specificity; Sulfhydryl Compounds; Tissue Inhibitor of Metalloproteinases; Trypsin | 1996 |
Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Humans; Metalloendopeptidases; Peptide Fragments; Phenylalanine; Phenylmercuric Acetate; Phosphorylation; Protease Inhibitors; Protein Structure, Tertiary; Receptor, ErbB-2; Thiophenes; Trastuzumab; Tumor Cells, Cultured | 2001 |